Congressman Sires’ Global Health Resolution Passes House of Representatives
(Washington, D.C.) – Yesterday, H.R. 1660, the Global Health Innovation Act of 2017, passed the House of Representatives by a vote of 423-3.
At the beginning of the 115th Congress, Rep. Albio Sires and Rep. Mario Diaz-Balart (R-FL) introduced this piece of legislation to promote the development of health products that are affordable, culturally appropriate, and easy to use in low-resource health systems.
“Infectious diseases, malnutrition, and complications of pregnancy and childbirth still claim the lives of millions around the world. I am proud to sponsor this legislation, with my friend Congressman Diaz-Balart, which seeks to improve the United States’ leadership in global health care” said Rep. Sires. “Investing in global health research is a key part of our foreign policy which can help increase national security, bolster foreign relations around the globe, and protect millions from infectious diseases. The United States must continue to be a leader and build upon USAID’s advancements in global health. I am grateful for the support of my colleagues in the House of Representatives and look forward to H.R. 1660 being considered by the Senate”
Specifically, H.R. 1660 will provide the oversight needed to gain a clearer picture of the United States Agency for International Development's (USAID) global health research and development. Over the years, research and development projects have greatly expanded at USAID, searching for advancements towards an HIV and AIDS free generation, preventable maternal and childhood deaths, and preventable infectious diseases. H.R. 1660 directs the USAID Administrator to report to Congress on the development and use of global health innovations in USAID programs, projects, and activities, ensuring that taxpayer dollars are being spent in the most efficient and effective ways possible.
Rep. Mario Diaz-Balart stated “I am proud to have again joined my friend, Congressman Sires, in introducing the Global Health Innovation Act. Investments in global health research and development are critical to making the world a safer, healthier place. These investments are critical to our national security, and will allow our researchers to deliver state-of-the-art medical devices and technologies abroad. The United States leads the world in global health R&D, and it is important that we continue to support programs in this field.”